Media Relations

Lundbeck seeks an open and active dialogue with the press. Members of the press are always welcome to direct enquiries to our press contacts who work to serve members of the press quickly and professionally.

We are always available to take your enquiries. Please send an email or give us a call. For general press enquiries, please call +45 3643 4000.

Please note that the contacts listed to the right are for journalists or people with media related questions. If you are not a journalist, please visit the contact page and consult the appropriate Lundbeck contact.

About Lundbeck

Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with brain diseases. For this purpose, Lundbeck is engaged in the research, development, manufacturing, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at the disease areas within psychiatry and neurology.

Focus on R&D is the most important pillar in Lundbeck’s ambition to improve treatment for people living with brain diseases. We are specialists in our area and have research facilities in Denmark and California. We cooperate closely with strategic partners all over the world, ensuring the best possible foundation for innovation and the development of new treatment solutions.

Lundbeck employs approximately 5,800 people worldwide. We have employees in more than 50 countries, and our products are registered in more than 100 countries. We have production facilities in Denmark, France and Italy and our research centers are based in Denmark and California. Lundbeck generated revenue of DKK 17.03 billion in 2019.

Contact Corporate Communication

Juliane Lenzner

Juliane Lenzner

Vice President, Head of Global Communication & Public Affairs

Phone: +4530832215

Contact me

Mikkel Ballegaard Pedersen

Mikkel Ballegaard Pedersen

Video Journalist

Phone: +4530832044

Contact me

Cookie Policy
You have chosen to leave Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on